These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 16423997
1. De novo CpG island methylation in human cancer cells. Jair KW, Bachman KE, Suzuki H, Ting AH, Rhee I, Yen RW, Baylin SB, Schuebel KE. Cancer Res; 2006 Jan 15; 66(2):682-92. PubMed ID: 16423997 [Abstract] [Full Text] [Related]
2. DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR. Nat Genet; 2003 Jan 15; 33(1):61-5. PubMed ID: 12496760 [Abstract] [Full Text] [Related]
3. Preference of DNA methyltransferases for CpG islands in mouse embryonic stem cells. Hattori N, Abe T, Hattori N, Suzuki M, Matsuyama T, Yoshida S, Li E, Shiota K. Genome Res; 2004 Sep 15; 14(9):1733-40. PubMed ID: 15310660 [Abstract] [Full Text] [Related]
4. Mithramycin A inhibits DNA methyltransferase and metastasis potential of lung cancer cells. Lin RK, Hsu CH, Wang YC. Anticancer Drugs; 2007 Nov 15; 18(10):1157-64. PubMed ID: 17893516 [Abstract] [Full Text] [Related]
5. Comparative analysis of DNA methylation patterns in transgenic Drosophila overexpressing mouse DNA methyltransferases. Mund C, Musch T, Strödicke M, Assmann B, Li E, Lyko F. Biochem J; 2004 Mar 15; 378(Pt 3):763-8. PubMed ID: 14636159 [Abstract] [Full Text] [Related]
6. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites. Gowher H, Jeltsch A. J Mol Biol; 2001 Jun 22; 309(5):1201-8. PubMed ID: 11399089 [Abstract] [Full Text] [Related]
7. DNA methylation in ovarian cancer. II. Expression of DNA methyltransferases in ovarian cancer cell lines and normal ovarian epithelial cells. Ahluwalia A, Hurteau JA, Bigsby RM, Nephew KP. Gynecol Oncol; 2001 Aug 22; 82(2):299-304. PubMed ID: 11531283 [Abstract] [Full Text] [Related]
8. Abnormal CpG island methylation occurs during in vitro differentiation of human embryonic stem cells. Shen Y, Chow J, Wang Z, Fan G. Hum Mol Genet; 2006 Sep 01; 15(17):2623-35. PubMed ID: 16870691 [Abstract] [Full Text] [Related]
9. DNA (cytosine-5)-methyltransferases in mouse cells and tissues. Studies with a mechanism-based probe. Yoder JA, Soman NS, Verdine GL, Bestor TH. J Mol Biol; 1997 Jul 18; 270(3):385-95. PubMed ID: 9237905 [Abstract] [Full Text] [Related]
10. Genetic unmasking of epigenetically silenced tumor suppressor genes in colon cancer cells deficient in DNA methyltransferases. Paz MF, Wei S, Cigudosa JC, Rodriguez-Perales S, Peinado MA, Huang TH, Esteller M. Hum Mol Genet; 2003 Sep 01; 12(17):2209-19. PubMed ID: 12915469 [Abstract] [Full Text] [Related]
11. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Jacinto FV, Ballestar E, Ropero S, Esteller M. Cancer Res; 2007 Dec 15; 67(24):11481-6. PubMed ID: 18089774 [Abstract] [Full Text] [Related]
12. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells. Gebhard C, Benner C, Ehrich M, Schwarzfischer L, Schilling E, Klug M, Dietmaier W, Thiede C, Holler E, Andreesen R, Rehli M. Cancer Res; 2010 Feb 15; 70(4):1398-407. PubMed ID: 20145141 [Abstract] [Full Text] [Related]
13. DNA methyltransferase 1 expression and promoter methylation of E-cadherin in mucoepidermoid carcinoma. Shieh YS, Shiah SG, Jeng HH, Lee HS, Wu CW, Chang LC. Cancer; 2005 Sep 01; 104(5):1013-21. PubMed ID: 15999364 [Abstract] [Full Text] [Related]
14. Elevated mRNA levels of DNA methyltransferase-1 as an independent prognostic factor in primary nonsmall cell lung cancer. Kim H, Kwon YM, Kim JS, Han J, Shim YM, Park J, Kim DH. Cancer; 2006 Sep 01; 107(5):1042-9. PubMed ID: 16888795 [Abstract] [Full Text] [Related]
15. CpG island hypermethylation is maintained in human colorectal cancer cells after RNAi-mediated depletion of DNMT1. Ting AH, Jair KW, Suzuki H, Yen RW, Baylin SB, Schuebel KE. Nat Genet; 2004 Jun 01; 36(6):582-4. PubMed ID: 15156141 [Abstract] [Full Text] [Related]
16. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers. Xiong Y, Dowdy SC, Xue A, Shujuan J, Eberhardt NL, Podratz KC, Jiang SW. Gynecol Oncol; 2005 Mar 01; 96(3):601-9. PubMed ID: 15721400 [Abstract] [Full Text] [Related]
17. Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer. Schlesinger Y, Straussman R, Keshet I, Farkash S, Hecht M, Zimmerman J, Eden E, Yakhini Z, Ben-Shushan E, Reubinoff BE, Bergman Y, Simon I, Cedar H. Nat Genet; 2007 Feb 01; 39(2):232-6. PubMed ID: 17200670 [Abstract] [Full Text] [Related]
18. CXXC domain of human DNMT1 is essential for enzymatic activity. Pradhan M, Estève PO, Chin HG, Samaranayke M, Kim GD, Pradhan S. Biochemistry; 2008 Sep 23; 47(38):10000-9. PubMed ID: 18754681 [Abstract] [Full Text] [Related]
19. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning. Hinshelwood RA, Melki JR, Huschtscha LI, Paul C, Song JZ, Stirzaker C, Reddel RR, Clark SJ. Hum Mol Genet; 2009 Aug 15; 18(16):3098-109. PubMed ID: 19477956 [Abstract] [Full Text] [Related]
20. Profound flanking sequence preference of Dnmt3a and Dnmt3b mammalian DNA methyltransferases shape the human epigenome. Handa V, Jeltsch A. J Mol Biol; 2005 May 20; 348(5):1103-12. PubMed ID: 15854647 [Abstract] [Full Text] [Related] Page: [Next] [New Search]